Remembering Ray Chow
We are greatly saddened to share news of the passing of our friend and colleague, Ray Chow, on Thursday, November 24, 2022, after a difficult illness. Ray was an advisor and board member of SeaStar Medical for three years, including as Chairman of...
Remembering SeaStar Medical’s Shareholder and Cherished Friend, Jeff Goldstein
We are greatly saddened to announce the passing of Jeff Goldstein on June 27th, a long-serving trusted Shareholder and cherished friend of SeaStar Medical. As a committed business leader and transplant advocate, Jeff was dedicated to impacting...
SeaStar Medical Completes Enrollment of SCD 005 Trial to Evaluate Safety of SCD in AKI and/or ARDS Patients with COVID-19
SeaStar Medical recently completed enrollment of its SCD-005 clinical trial to demonstrate the safety of Selective Cytopheretic Device (SCD) in acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) with COVID-19 infection. This...